We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Name | Symbol | Market | Type |
|---|---|---|---|
| Roche Holdings Ltd AG (QX) | USOTC:RHHBY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.23 | 0.77% | 30.25 | 30.15 | 30.26 | 30.28 | 30.07 | 30.10 | 2,908,982 | 22:20:00 |
From Apr 2019 to Apr 2024
By Matt Grossman
Roche Holding AG on Friday said it has received an emergency-use authorization from the U.S. Food and Drug Administration for a test that can distinguish between Covid-19 and the flu.
The test is for Roche's cobas 6800/8800 system, which can process between 384 and 1,056 tests in an eight-hour period depending on the model used.
Roche said the test will help health-care providers determine which patients are sick with the flu and which are sick with Covid-19--a determination that will grow in importance as flu season approaches.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
September 04, 2020 07:11 ET (11:11 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Roche (QX) Chart |
1 Month Roche (QX) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
